Flotek Reports Q3 2026 Revenue Growth and Raises Full-Year Guidance
Flotek (FTK) reported strong third-quarter results for 2026, with revenue reaching $114.4 million, a 104% increase year-over-year. This growth was fueled by triple-digit expansions in both the company's chemistry and data analytics segments. Adjusted EBITDA rose 87% to $19.5 million, benefiting from increased volume and improved general and administrative leverage. Driven by these results, management raised its full-year revenue guidance to a range of $382 million to $390 million and increased its adjusted EBITDA outlook to between $59 million and $62 million. While net income decreased compared to the prior year due to the absence of a one-time tax benefit, the company's international chemistry sales saw significant expansion, now accounting for 25% of total revenue.
Tickers: $FTK
Topics: EBITDA guidance international expansion revenue growth segment performance